MTM. Alejandra Tricerri

M. Alejandra Tricerri

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


M. Alejandra Tricerri has a total of 74 co-authors. Here are the top co-authors by number of shared publications:

  • Romina A. Gisonno

    Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), Argentina

    7 shared publications
  • Silvana A. Rosú

    Facultad de Ciencias Médicas, Instituto de Investigaciones Bioquímicas de La Plata “Dr Prof. Rodolfo R. Brenner” (INIBIOLP), CONICET, Universidad Nacional de La Plata, Buenos Aires, Argentina

    7 shared publications
  • Eduardo D. Prieto

    Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas (INIFTA) Universidad Nacional de La Plata-CONICET, La Plata, Buenos Aires, Argentina

    5 shared publications
  • Gabriela S. Finarelli

    Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), CONICET. Facultad de Ciencias Médicas, Universidad Nacional de La Plata, Calle 60 y 120, La Plata, Buenos Aires, Argentina

    5 shared publications
  • Guillermo Raúl Schinella

    School of Medical Sciences, National University of La Plata, Avenue 60 and 120, La Plata 1900, BA, Argentina

    5 shared publications
  • Nahuel A. Ramella

    Instituto de Investigaciones Bioquímicas de La Plata "Prof. Dr. Rodolfo R. Brenner" (INIBIOLP), CONICET, CCT-La Plata, La Plata, Buenos Aires, Argentina; Facultad de Ciencias Médicas, Universidad Nacional de La Plata (UNLP), La Plata, Buenos Aires, Argentina

    5 shared publications

Latest Publications

  • Studying biological events using biopolymeric matrices

    by Joao Aguilar, Silvana A. Rosú, José Ulloa, German Gunther, Bruno F. Urbano, M. Alejandra Tricerri, Susana A. Sánchez

    Traditional methodologies to study in vitro biological processes include simplified laboratory models where different parameters can be measured in a very controlled environment. The most used of these practices is cell plate-culturing in aqueous media. In this minimalistic model, essential components of the biological system might be ignored. One of them, disregarded for a long time, is the extracellular matrix (ECM). Extracellular matrix in eukaryotic cells is not only a frame for cells and biological components, but also an active partner of cellular metabolism and participates in several normal and pathological biological processes in a dynamic manner. ECM of eukaryotic cells has a very complex structure. Also, its mechanical properties (stiffness, viscoelasticity) depend on the organ it is associated with, and may vary from a very fluid (plasma) to a very solid (bones) structure. ECM structure and composition are very dynamic and experience temporal structural and topological changes, affecting all the existing interactions. When mimicking the ECM, three aspects are considered: the chemical environment and the physical and structural properties. In this review, we present two lines of research studying the role of the ECM in two biological implications: membrane fluidity heterogeneity and protein retention and aggregation. For these studies, we used biopolymeric matrices with very controlled features to evaluate the two events. We use traditional biochemical techniques and fluorescence microscopy to study the biological systems and traditional polymer techniques (rheology, SEM) to characterize the polymeric matrices.


  • Hereditary Amyloidosis: insights into a fibrinogen A variant diagnosis PC14 (#153)

    by Maria Alejandra, Elizabeth R., Romina A., Martín C., Marianela Santana, Silvana A., Elsa Nucifora, Maria Adela, María C., Nahuel A.

    **Author Listing - Lead/ Submitting Author (we will be communicating with this individual): Name, Institution, City and State where the work was | POSTER

  • Interactions of variants of human apolipoprotein A-I with biopolymeric model matrices. Effect of collagen and heparin. OC18 (#155)

    by Maria Alejandra, Silvana A., Joao Aguilar, Bruno F., Wilson A., Nahuel A., Gabriela S., Susana A.

    **Author Listing - Lead/ Submitting Author (we will be communicating with this individual): Name, Institution, City and State where the work was | POSTER

  • Interactions of variants of human apolipoprotein A-I with biopolymeric model matrices. Effect of collagen and heparin

    by Silvana A. Rosú, Joao Aguilar, Bruno F. Urbano, Wilson A. Tarraga, Nahuel A. Ramella, Gabriel S. Longo, Gabriela S. Finarelli, Susana A. Sanchez Donoso, M. Alejandra Tricerri


  • Evolutionary and structural constraints influencing apolipoprotein A-I amyloid behavior

    by Romina A. Gisonno, Tomas Masson, Nahuel A. Ramella, Exequiel E. Barrera, Víctor Romanowski, M. Alejandra Tricerri

    Apolipoprotein A-I (apoA-I) has a key function in the reverse cholesterol transport. However, aggregation of apoA-I single point mutants can lead to hereditary amyloid pathology. Although several studies have tackled the biophysical and structural consequences introduced by these mutations, there is little information addressing the relationship between the evolutionary and structural features that contribute to the amyloid behavior of apoA-I. We combined evolutionary studies, in silico mutagenesis and molecular dynamics (MD) simulations to provide a comprehensive analysis of the conservation and pathogenic role of the aggregation-prone regions (APRs) present in apoA-I. Sequence analysis demonstrated that among the four amyloidogenic regions described for human apoA-I, only two (APR1 and APR4) are evolutionary conserved across different species of Sarcopterygii. Moreover, stability analysis carried out with the FoldX engine showed that APR1 contributes to the marginal stability of apoA-I. Structural properties of full-length apoA-I models suggest that aggregation is avoided by placing APRs into highly packed and rigid portions of its native fold. Compared to silent variants extracted from the gnomAD database, the thermodynamic and pathogenic impact of amyloid mutations showed evidence of a higher destabilizing effect. MD simulations of the amyloid variant G26R evidenced the partial unfolding of the alpha-helix bundle with the concomitant exposure of APR1 to the solvent, suggesting an insight into the early steps involved in its aggregation. Our findings highlight APR1 as a relevant component for apoA-I structural integrity and emphasize a destabilizing effect of amyloid variants that leads to the exposure of this region.


  • Understanding the role of apolipoproteinA-I in atherosclerosis. Post-translational modifications synergize dysfunction?

    by Ivo Díaz Ludovico, Romina A. Gisonno, Marina C. Gonzalez, Horacio A. Garda, Nahuel A. Ramella, M. Alejandra Tricerri


  • Open Access

    Evolutionary and Structural Constraints Influencing Apolipoprotein A-I Amyloid Behaviour

    by Ra Gisonno, T Masson, N Ramella, Ee Barrera, V Romanowski, Ma Tricerri

    Apolipoprotein A-I (apoA-I) has a key function in the reverse cholesterol transport mediated by the high density lipoprotein (HDL) particles. However, aggregation of apoA-I single point mutants can lead to hereditary amyloid pathology. Although several studies have tackled the biophysical and structural impacts introduced by these mutations, there is little information addressing the relationship between the evolutionary and structural features that contribute to the amyloid behavior of apoA-I. We combined evolutionary studies, in silico mutagenesis and molecular dynamics (MD) simulations to provide a comprehensive analysis of the conservation and pathogenic role of the aggregation-prone regions (APRs) present in apoA-I. Sequence analysis demonstrated that among the four amyloidogenic regions described for human apoA-I, only two (APR1 and APR4) are evolutionary conserved across different species of Sarcopterygii. Moreover, stability analysis carried out with the FoldX engine showed that APR1 contributes to the marginal stability of apoA-I. Structural properties of the full-length apoA-I model suggest that aggregation is avoided by placing APRs into highly packed and rigid portions of its native fold. Following we set up to study the effect of natural mutations on protein conformation and stability. Compared to natural silent variants extracted from the gnomAD database, the thermodynamic and pathogenic impact of apoA-I amyloid mutations showed evidence of a higher destabilizing effect. MD simulations of the amyloid variant G26R evidenced the partial unfolding of the alpha-helix bundle with the concomitant exposure of APR1 to the solvent and the formation of beta-sheet segments at the C-terminus of apoA-I, giving a possible hint about the early steps involved in its aggregation. Our findings highlight APR1 as a relevant component for apoA-I structural integrity and emphasize a destabilizing effect of amyloid variants that leads to the exposure of this region. This information contributes to our understanding of how apoA-I, with its high degree of structural flexibility, maintains a delicate equilibrium between its monomeric native structure and intrinsic tendency to form amyloid aggregates. In addition, our stability measurements could be used as a proxy to interpret the structural impact of new mutations.


  • Open Access

    Data regarding the sensibility to proteolysis of a natural apolipoprotein A-I mutant.

    by Gisela M. Gaddi, Romina A. Gisonno, Silvana A. Rosú, M. Fernanda Cortez, Gabriela S. Finarelli, Nahuel A. Ramella, M. Alejandra Tricerri

  • Open Access

    Understanding the role of apolipoproteinA-I in atherosclerosis. Post-translational modifications synergize dysfunction?

    by Ivo Díaz Ludovico, Romina A. Gisonno, Marina C. Gonzalez, Horacio A. Garda, Nahuel A. Ramella, M. Alejandra Tricerri

    Background The identification of dysfunctional human apolipoprotein A-I (apoA-I) in atherosclerotic plaques suggests that protein structure and function may be hampered under a chronic pro inflammatory scenario. Moreover, the fact that natural mutants of this protein elicit severe cardiovascular diseases (CVD) strongly indicates that the native folding could shift due to the mutation, yielding a structure more prone to misfold or misfunction. To understand the events that determine the failure of apoA-I structural flexibility to fulfill its protective role, we took advantage of the study of a natural variant with a deletion of the residue lysine 107 (K107del) associated with atherosclerosis. Methods Biophysical approaches, such as electrophoresis, fluorescence and spectroscopy were used to characterize proteins structure and function, either in the native conformation or under oxidation or intramolecular crosslinking. Results K107del structure was more flexible than the protein with the native sequence (Wt) but interactions with artificial membranes were preserved. Instead, structural restrictions by intramolecular crosslinking impaired the Wt and K107del lipid solubilization function. In addition, controlled oxidation decreased the yield of the native dimer conformation for both variants. Conclusions We conclude that even though mutations may alter protein structure and spatial arrangement, the highly flexible conformation compensates the mild shift from the native folding. Instead, post translational apoA-I modifications (probably chronic and progressive) are required to raise a protein conformation with significant loss of function and increased aggregation tendency. General Significance The results learnt from this variant strength a close association between amyloidosis and atherosclerosis. Highlights -Oxidation is clue to induce protein misfolding -Natural mutation does not seem critical as a sole reason to determine pathogenicity -Atherosclerosis and amyloidosis are closely related -Intramolecular crosslinking restrains protein flexibility and function